Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Martek Biosciences Shares Skyrocketed: What You Need to Know

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Martek Biosciences (Nasdaq: MATK  ) saw its shares soar a staggering 35% in early Tuesday trading after Dutch vitamin giant Royal DSM NV said it will bid $1.09 billion for the company.

So what: Martek's leading position in the dietary supplements market will, according to Royal DSM CEO Feike Sijbesma, "add a new growth platform to our nutrition business." The buyout price represents a 35% premium to Martek's closing price on Monday, and with the transaction having already been recommended by its board of directors, Mr. Market feels pretty confident about the deal going through.

Now what: With the shares up near the buyout price, there's very little for Martek shareholders to do now but lighten up on the position and celebrate. While it might be tempting to hold out for a higher offer, the risk (even if it's small) that the deal will end up falling through isn't worth taking on. For the rest of us who weren't lucky enough to get in on today's buyout bonanza, one of Martek's biggest customers, Mead Johnson (NYSE: MJN  ) , might be a decent way to invest in the dietary supplements space.

Interested in more info on Martek? Add it to your watchlist.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Try any of our Foolish newsletter services free for 30 days.

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1406844, ~/Articles/ArticleHandler.aspx, 10/28/2016 6:18:58 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,161.19 -8.49 -0.05%
S&P 500 2,126.41 -6.63 -0.31%
NASD 5,190.10 -25.87 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/25/2011 4:00 PM
MATK.DL $31.49 Down +0.00 +0.00%
Martek Biosciences… CAPS Rating: ****
MJN $76.20 Up +1.55 +2.08%
Mead Johnson Nutri… CAPS Rating: ***